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An observational study on cough in children:
epidemiology, impact on quality of sleep and
treatment outcome
Francesco De Blasio1*, Peter V Dicpinigaitis2, Bruce K Rubin3, Gianluca De Danieli4, Luigi Lanata4 and
Alessando Zanasi5

Abstract
Background: Cough is one of the most frequent symptoms in children and is the most common symptom for
which children visit a health care provider.
Methods: This is an observational study on acute cough associated with upper respiratory tract infection (URTI) in
children. The study evaluates the epidemiology and impact of cough on quality of sleep and children’s activities,
and the outcome of cough with antitussive treatments in pediatric routine clinical practice. Study assessments
were performed through a pediatric cough questionnaire (PCQ), developed by the Italian Society of Cough Study.
A total of 433 children visited by family care pediatricians for acute cough due to a URTI were enrolled in this
study, with mean age of 6.1 years (SD 3.6). Cough type, duration, severity and frequency, cough impact on sleep
disturbances of children and parents and on school and sport activities were assessed at baseline. In a subset of
241 children who were either treated with antitussive drugs (levodropropizine n = 101, central antitussives n = 60)
or received no treatment (n = 80), the outcome of cough after 6 days was analyzed in terms of resolution,
improvement, no change, or worsening. Descriptive analysis, c2 test, and multivariate analysis with stepwise logistic
regression were performed.
Results: Cough disturbed sleep in 88% of children and 72% of parents. In children treated with cough
suppressants, the duration, type, intensity, and frequency cough were similar at baseline in the two groups
respectively treated with levodropropizine and central antitussives (cloperastine and codeine). Both
levodropropizine and central drugs reduced cough intensity and frequency. However, percentage of cough
resolution was higher with levodropropizine than with central antitussives (47% vs. 28% respectively, p = 0.0012).
Conclusions: Acute cough disturbs sleep in most children and their parents. Both levodropropizine and central
antitussives reduced cough intensity, with levodropropizine producing a higher cough resolution rate.
Keywords: Cough, Antitussive, Children, Levodropropizine, Cloperastine, Codeine

Background
Cough is one of the most frequent symptoms in children [1,2] and is one of the most common reasons for
which parents seek medical attention for their child [3].
In most children, acute cough is due to viral upper
respiratory tract infection (URTI), i.e., the common cold
[4]. It is recognized that preschool and school children
* Correspondence: dicearchia@gmail.com
1
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might suffer from acute respiratory infections 6 to 8
times a school year and can cough 140 coughs daily
with a URTI [5].
Cough resulting from URTI may be a distressing
symptom, and empiric treatment with antitussive agents
is often used [6]. Among antitussive drugs available for
the treatment of cough in children, codeine and cloperastine are centrally acting agents (opioids and non
opioids) that are believed to inhibit cough primarily by
their effect on the cough center, while levodropropizine
is a non-opioid agent whose suggested peripheral
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antitussive action may result from inhibition of the
cough reflex at the peripheral nerve level (sensory Cfibres) [7] with possible modulation of sensory neuropeptide levels within the respiratory tract [8].
The aim of this study was to evaluate the epidemiology of acute cough associated with URTI in children,
the impact of acute cough on quality of sleep of children
and their parents, the impact of acute cough on children’s sport and school activities, and acute cough outcome with antitussive treatments.

Methods
This is an observational study on pediatricians’ routine
clinical practice, including all children who presented to
the offices of four family care pediatricians due to acute
cough (i.e., onset ≤ 3 weeks) associated with a URTI
from 1st February 2010 to 30th April 2010. Study
assessments were performed through a specific pediatric
cough questionnaire (PCQ), developed and approved by
the Scientific Committee of the Italian Society of Cough
Study (see Appendix). Baseline assessment was performed during the first study visit by the pediatrician,
who interviewed parents and/or patients and compiled
the first part of the PCQ, addressing the evaluation of
type, duration, frequency and severity of cough, sleep
disturbances of both children and parents (quality of
sleep), and impact of cough on school activities and
sports/games. Pediatricians were free to prescribe the
most appropriate treatments for cough based on their
clinical practice experience. The PCQ was given to the
children’s parents for self assessment to be performed
after 6 days from the first study visit, compiling the second part of the questionnaire reporting actually administered treatments, and the outcome of cough in terms
of resolution, improvement, no change, or worsening.
Patients were revisited after one week from the first
visit, and questionnaires were collected by the physician,
as well as any adverse events experienced by the child.
Statistics

Continuous data are presented as mean +/- standard
deviation. Categorical and discrete data are presented as
frequency and percentages. Differences between groups
were tested using the c2 test for categorical and discrete
variables. A multivariate analysis was performed. Using a
stepwise logistic regression we assessed how changes in
cough severity related to the age of children, the presence
of concomitant respiratory diseases, the type of cough,
the use of antibiotics, and the antitussive therapy used.

Results
Epidemiology of Cough

The total number of children enrolled in this study
was 433. The mean age of children was 6.1 years (SD

Figure 1 Age of enrolled children.

3.6 - median 5.2 years). The youngest enrolled was 1
month, while the oldest was 14 years (Figure 1).
Clinical findings

Clinical data including type, duration, frequency and
severity of cough were recorded on the PCQ at the first
study visit. In 88 (20.3%) patients a concomitant illness
was found. Allergies were the most frequent conditions
with an incidence of 9% (Table 1).
Frequency and intensity of cough were mostly
reported as frequent and moderate, respectively
(Table 2).
Quality of sleep, sport and school activities

The PCQ evaluated the impact of cough on quality of
sleep in children and their parents through four questions (Figure 2):
To what extent did cough symptoms disturb children’s
sleep?
To what extent did children’s cough symptoms disturb
their parent’s sleep?
To what extent did children’s cough symptoms interfere in their scholastic activities?
To what extent did children’s cough symptom interfere with sport activities?
Regarding pre-scholar children and infants, scholastic
activities were to be intended as activities at kindergarten/nursery/crèche, while sport activities were to be
intended as games.

Table 1 Concomitant Respiratory Illnesses
Concomitant respiratory illnesses

20.3%

Allergies

9.0%

Asthma

6.2%

Bronchitis

3.0%

Rhinitis/Sinusitis

1.6%

Tonsillitis

0.5%
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Table 2 Intensity and Frequency of cough
Intensity of Cough

Total

Mild

81 (18.7%)

Moderate

237 (54.7%)

Severe

115 (26.6%)

Total

433 (100%)

Frequency of Cough

Total

Occasional

126 (29.1%)

Frequent

258 (59.6%)

Continuous
Total

49 (11.3%)
433 (100%)

Treatment of Cough

Of the total 433 patients, 80 received no treatment for
cough since the doctor did not prescribe any medication, while 161 were treated with cough suppressant
agents, which were the main drugs used in this study.
Of these, 101 children received levodropropizine and 60
patients were treated with central antitussives (51 with
cloperastine, and 9 with codeine).
The outcome of cough after 6 days was analyzed in
terms of resolution, improvement, no change, or worsening in this subset of 241 children who were treated
with antitussive drugs or received no treatment.
Regarding patients’ characteristics at baseline (Table
3), the two groups respectively treated with levodropropizine and central antitussives (cloperastine and
codeine) were similar for cough duration (number of
days since cough onset), cough type, intensity, and frequency. Average age of patients treated with central
antitussives was approximately 1 year and a half higher
than patients who received levodropropizine, and this
appears to be consistent with current routine clinical
practice in the pediatric population, considering that
codeine is contraindicated in children below 2 years. As
expected in a real life observational study in which therapeutic decisions were driven by physicians’ opinions
based on their clinical practice experience, cough intensity and frequency were significantly lower in the group

Figure 2 Quality of sleep, sport and school activities.

of patients for which pediatricians decided not to prescribe any treatment than in the two groups treated
with levodropropizine and central antitussives,
respectively.
Correlation between treatment outcome and type of
treatment received

There was a significant difference in treatment outcomes between the groups receiving levodropropizine
and those receiving central antitussives. The percentage
of children reporting cough resolution was significantly
higher with levodropropizine than with central antitussives (47% vs. 28% respectively, p = 0.0012), and no
change/worsening was reported in 3% receiving levodropropizine vs. 18% for central antitussives (Figure 3).
Twenty per cent of patients receiving no therapy
reported resolution of cough, while 55% reported
improvement of their symptoms.
Correlation between intensity of cough and treatment
outcomes
Moderate cough

Levodropropizine showed better treatment results than
central antitussives and no therapy. A statistically significant difference was found (p < 0.05) in terms of percentage of cough resolution. Only 3% of patients in the
levodropropizine group reported no change or worsening of cough symptoms vs. 22% and 37% for central
antitussives and no therapy, respectively (Figure 4).
Severe Cough

No patients who received levodropropizine reported no
change/worsened cough (Figure 5).
Multivariate Analysis (Step-wise Logistic Regression)

A multivariate analysis by stepwise logistic regression
was done to evaluate the probability of cough improvement related to clinical characteristics. The independent
variable was resolution or improvement of cough while
covariates were: age (continuous - months), concomitant
diseases (Yes vs. No), type of cough (productive, dry, or
mixed), association with antibiotics (Yes vs. No), antitussive therapy (levodropropizine, central antitussive, or
none). The coefficients values derived from the logistic
regression are shown in Table 4.
Cough resolution or improvement was most strongly
associated with the type of antitussive used and type of
cough. Children with productive cough tended to respond
better than patients with mixed cough. Cough outcome
was better with levodropropizine than with central antitussives. No statistically significant correlation was found with
age, concomitant diseases or use of antibiotics.

Discussion
Of the 433 children enrolled in this observational study,
52% were preschool ( < 6 years). The mean age of
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Table 3 Patients Characteristics at Baseline
Levodropropizine Central Antitussives (CA) n =
(LDP) n = 101
60

No Treatment (NT) n =
80

p
* p < 0,05 LDP. vs
CA

Age (years), mean (min-max)

5.9* (0.8-14.8)

7.3 (1.6-13.3)

6.3 (0.3-14.0)

Cough Duration (days), mean (minmax)

4.6 (2-15)

5.8 (2-21)

4.7 (2-17)

NS

Productive

36.6%

25.0%

46.3%

NS

Dry
Mix

50.5%
12.9%

63.3%
11.7%

40.0%
13.8%

NS
NS

Mild

7.9%

8.3%

42.5%*

*p < 0.01 NT vs LDP/
CA

Moderate

58.4%

53.3%

51.3%

NS

Severe

33.7%

38.3%

6.3%*

*p < 0.01 NT vs LDP/
CA

Occasional

18.8%

10.0%

60.0%

NS

Frequent

65.3%

75.0%

36.3%

NS

Continuous

15.8%

15.0%

3.8%*

*p < 0.01 NT vs LDP/
CA

NS LDP vs NT
NS CA vs NT

Cough Type (%)

Cough Intensity (%)

Cough Frequency (%)

children was 6.2 years. In 88% of patients, acute cough
due to URTI disturbed the children’s quality of sleep,
and the scholastic and sport activities were affected in
76% and 61% of children, respectively. The quality of
parent’s sleep was affected in 72% in parents
In the subset of 241 children who were treated with
antitussive drugs (levodropropizine or central antitussives, n = 161) or received no treatment (n = 80), 80%
were reported to have moderate or severe cough. More
children were treated with levodropropizine (n = 101)
than with central cough suppressants (codeine and cloperastine, n = 60). All antitussive drugs reduced cough

Figure 3 Treatments outcomes. Chi sq. (2 DF) = 13,4121, p = 0,0012

intensity and frequency. However, cough resolution was
significantly higher with levodropropizine than with central antitussives (47% vs. 28% respectively, p = 0.0012).
The results of a logistic analysis suggest that the use of
antibiotics had no significant correlation with cough
improvement. Multivariate analysis showed a statistically
significant difference of cough improvement with levodropropizine vs. central antitussives or no therapy, independent of antibiotic use or concomitant illnesses.
In conclusion, cough significantly disturbed children’s
and parents’ sleep and daily activities. Levodropropizine
was the antitussive drug most commonly used by the
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Figure 4 Treatments outcomes - Moderate cough.

Figure 5 Treatments outcomes - Severe cough.

pediatricians in this study, and cough outcome in terms
of resolution and improvement appeared to be better
with levodropropizine than with centrally acting antitussives (cloperastine and codeine).
Further large randomized clinical trial in children
should be conducted in order to confirm the efficacy of
antitussive drugs used in this observational study.
Table 4 Logistic analysis
COVARIATES

Contrast

Age (months)

Continuous

-0.003 0.0033 0.311

Concomitant diseases Yes

vs. No

0.584

Productive cough

vs. dry

-0.144 0.3200 0.652

vs. mixed
Association with antibiotics vs. No
Yes
Levodropropizine
vs. Central
antitussives
vs. No Treatment

Coeff. SE

p
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